• Itraconazole: Advanced Workflows for Candida Biofilm & Drug

  2026-07-20

  Itraconazole stands out as a triazole antifungal agent, enabling both mechanistic studies of Candida drug resistance and translational antifungal research. This article details advanced, evidence-driven workflows and practical troubleshooting to maximize APExBIO’s Itraconazole in biofilm, drug interaction, and angiogenesis inhibition assays.

• Resazurin Cell Viability Assay Kit: Precision for Proliferat

  2026-07-19

  The Resazurin Cell Viability Assay Kit from APExBIO delivers unmatched sensitivity and non-toxicity for quantifying live cell populations, streamlining workflows across diverse biological applications. Its dual-mode detection and ready-to-use format set a new standard for high-throughput, reproducible viability analysis.

• Flavopiridol (L868275): Precision Cell Cycle Arrest in Cance

  2026-07-18

  Flavopiridol (L868275) from APExBIO sets the benchmark in selective cyclin-dependent kinase inhibition, empowering researchers to induce robust cell cycle arrest and apoptosis across cancer and stem cell models. This article delivers actionable workflows, troubleshooting strategies, and protocol guidance, drawing on recent mechanistic insights and real-world data to maximize experimental reproducibility and translational impact.

• Zosuquidar (LY335979): Precision MDR Reversal in Cancer Mode

  2026-07-17

  Zosuquidar (LY335979) 3HCl offers bench scientists a selective, evidence-backed approach to overcome multidrug resistance (MDR) in cancer models, restoring chemotherapeutic sensitivity across diverse cell types. This guide delivers actionable workflows, troubleshooting insights, and protocol optimizations to maximize the impact of Zosuquidar in combination therapy and resistance mechanism research.

• Quercetin Suppresses NLRP3 Inflammasome in LPS-Induced Depre

  2026-07-17

  This study demonstrates that quercetin, a dietary flavonoid and PI3K inhibitor, alleviates depressive-like behaviors and cognitive dysfunction in a mouse model of LPS-induced depression by targeting the NLRP3 inflammasome pathway. These findings highlight quercetin's potential as a neuroprotective and anti-inflammatory agent in depression research.

• Oligo (dT) 25 Beads: Reliable mRNA Isolation for Cell Assays

  2026-07-16

  This article addresses real-world challenges in mRNA purification for cell viability and cytotoxicity assays, demonstrating how Oligo (dT) 25 Beads (SKU K1306) deliver robust, reproducible results. Scenario-driven insights and data-grounded recommendations empower biomedical researchers to achieve high-quality eukaryotic mRNA isolation, supporting downstream applications including RT-PCR and transcriptomic profiling.

• CBX2–RACK1–HDAC1 Complex Suppresses Tumor Immunogenicity

  2026-07-16

  This study uncovers a noncanonical mechanism by which CBX2, a polycomb group protein, suppresses interferon signaling and reduces tumor immunogenicity through formation of a corepressor complex with RACK1 and HDAC1. These findings clarify how CBX2 modulates the tumor microenvironment and suggest potential new targets and biomarkers for improving cancer immunotherapy.

• PD0325901: MEK Inhibitor Workflows for Cancer and Stem Cell

  2026-07-15

  PD0325901 empowers researchers to dissect RAS/RAF/MEK/ERK signaling with high precision, enabling robust models of cell cycle arrest and apoptosis induction. Discover advanced workflows, troubleshooting strategies, and data-driven protocol tips that maximize translational value in both cancer and stem cell studies.

• DR5 Agonist Antibodies Trigger Unexpected PD-L1 Immune Evasi

  2026-07-15

  The referenced study reveals that DR5 agonist antibodies, developed to induce apoptosis in solid tumors, unexpectedly stabilize PD-L1 on tumor cells, promoting immune evasion. This mechanistic insight challenges prior assumptions about the efficacy of extrinsic apoptosis-inducing therapies and informs combinatorial strategies for solid tumor immunotherapy.

• ICG001: Precision Wnt/β-Catenin Pathway Inhibitor in Transla

  2026-07-14

  ICG001 enables targeted dissection of CBP/β-catenin signaling, empowering researchers to model cancer, fibrosis, and stem cell fate with greater specificity. This article details best-practice workflows, troubleshooting, and the latest protocol insights to maximize the impact of ICG001 in applied biomedical research.

• Ruxolitinib (INCB018424): Protocols and Pitfalls in JAK-STAT

  2026-07-14

  Ruxolitinib (INCB018424) empowers high-fidelity JAK-STAT pathway inhibition, enabling precision in myeloproliferative disorder and immune modulation studies. This guide demystifies advanced workflows, protocol parameters, and troubleshooting strategies for leveraging Ruxolitinib in translational and preclinical research.

• ZDHHC4-Mediated Palmitoylation Regulates TRPV1 Pain Signalin

  2026-07-13

  This study uncovers how the palmitoyl acyltransferase ZDHHC4 modifies TRPV1 via S-palmitoylation, leading to its lysosomal degradation and attenuation of pain signaling. By elucidating the molecular interplay between palmitoylation and the relief phase of inflammatory pain, the findings provide a mechanistic foundation for targeting TRPV1 regulation in analgesic development.

• Aprotinin (BPTI) in Cardiovascular Research: Applied Workflo

  2026-07-13

  Leverage Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) from APExBIO for reproducible inhibition of serine proteases in cardiovascular and inflammation research. This guide delivers actionable workflows, troubleshooting tips, and protocol insights to maximize experimental success in perioperative blood loss reduction and red blood cell membrane studies.

• Oligo (dT) 25 Beads: Precision mRNA Isolation with Superpara

  2026-07-12

  Oligo (dT) 25 Beads enable rapid, high-purity eukaryotic mRNA isolation using superparamagnetic technology, streamlining workflows from total RNA extraction to next-generation sequencing. Explore advanced use-cases, optimization strategies, and troubleshooting tips to achieve maximal yield and purity, even in challenging experimental scenarios.

• Deuterated Tetrazole CYP51 Inhibitors: New Advances in Antif

  2026-07-10

  The referenced study introduces a deuterated tetrazole CYP51 inhibitor (V23) with broad-spectrum and in vivo antifungal efficacy, addressing limitations of earlier azole drugs such as metabolic instability and human CYP inhibition. This research advances the development of safer, more effective agents for invasive fungal infections, particularly those involving drug-resistant strains.

15487 records 1/1033 page Next 12345 下5页 Last page